Skin substitute procedures and wound debridement often occur during the same episode. Practices ask whether CPT 97597 or 11042 can be reported on the same date as a skin substitute application.
For Medicare claims, the general rule is clear: debridement performed at the recipient site to prepare a wound for a skin graft or skin substitute is included in the graft or skin substitute procedure. CMS states that debridement codes 11000–11047 and 97597–97598 are not separately reportable when the debridement is included in skin graft or skin substitute procedures coded 15050–15278.
However, debridement and skin substitute application can appear on the same claim when the services are genuinely distinct, supported by documentation, and allowed under applicable payer rules.
Skin substitute application codes describe placement of a graft or substitute over a prepared wound. Relevant CPT codes may include 15271–15278, depending on the procedure, site, and wound size.
When tissue is removed to prepare the same wound for the graft or skin substitute, that preparation is generally considered part of the application service. CMS’s 2026 NCCI Policy Manual specifically states that debridement of a skin wound before a graft or skin substitute is included in the procedure.
Therefore, performing debridement immediately before applying the product does not automatically justify reporting both services.
Consider a chronic ulcer with devitalized tissue. During the encounter, the clinician removes nonviable tissue, prepares the wound bed, and applies a skin substitute to the same site.
In this situation, billing the debridement separately may create a bundling problem. The debridement is part of preparing the recipient site. Documentation should describe the wound, tissue removed, depth treated, and application, but those details do not by themselves make debridement separately billable.
Codes 97597 and 97598 describe selective debridement, while 11042–11047 are used for surgical debridement based on tissue level. CMS emphasizes that the selected code must reflect the actual tissue removed and documented depth.
Two procedures performed on the same date can sometimes be distinct, but occurring during one visit is not enough to support separate reporting.
One possible example is treatment of separate anatomic sites where the debridement is unrelated to the skin substitute application. The record should identify separate wounds, procedures, locations, and medical necessity. An appropriate modifier may be necessary.
CMS explains that NCCI-associated modifiers such as 59, XE, XP, XS, and XU may be used in appropriate circumstances, including separate encounters or anatomic sites. They should not simply bypass a bundling edit.
Coders should review the specific NCCI edit, payer policy, and documentation before adding modifier 59 or an X{EPSU} modifier.
Strong documentation is the foundation of accurate wound care billing. For debridement, the record should support what was removed and why the service was medically necessary.
Useful documentation includes:
CMS guidance indicates that documentation for selective debridement should include an objective wound assessment and description of the instruments used. For surgical debridement, the record should support the actual depth and tissue level removed.
Documentation should describe the care accurately, not simply support a desired code.
Several errors can cause denials or compliance concerns when these procedures are reported together.
Before submitting a claim, confirm:
This review is valuable for practices managing high volumes of wound care claims. Effective Woundcare billing services should combine coding knowledge, documentation review, payer requirements, and claim level quality checks.
Medicare rules are a starting point, not a substitute for reviewing the payer’s current policy. Commercial insurers and Medicaid programs may apply different requirements, coverage limitations, or authorization rules.
For Medicare claims, the 2026 NCCI Policy Manual is an important reference. CMS also maintains wound care billing and coding guidance.
Because coding policies can change, practices should verify current NCCI edits and payer policies before applying a modifier or reporting two procedures together.
Generally, not when 97597 represents debridement performed to prepare the same recipient wound for the skin substitute. CMS considers this type of debridement included in the graft or skin substitute procedure.
Not simply because both procedures were performed. If 11042 represents preparation of the same wound for the skin substitute, it is generally included. A separately reportable service requires a distinct clinical circumstance supported by the record and applicable payer rules.
Modifier 59 does not automatically make bundled services separately payable. It may be appropriate only when the services meet requirements for a distinct service, such as a separate anatomic site or other qualifying circumstance under applicable NCCI rules.
Documentation should identify wound location, measurements, tissue characteristics, procedure performed, technique, depth, tissue removed, medical necessity, and skin substitute application details. Separate wounds should be clearly distinguished.
The safest approach is to focus on what each service actually represents. Debridement performed to prepare the same wound for a skin substitute is generally included in the application procedure. Separate reporting requires a genuinely distinct service, appropriate documentation, and compliance with applicable NCCI and payer requirements.
Careful coding, documentation, and claim review can reduce denials while supporting accurate reimbursement. Practices should verify current Medicare and payer guidance before submitting claims, particularly as wound care coding and coverage policies continue to change.
Skin substitute procedures and wound debridement often occur during the same episode. Practices ask whether CPT 97597 or 11042 can be reported on the same date as a skin substitute application.
For Medicare claims, the general rule is clear: debridement performed at the recipient site to prepare a wound for a skin graft or skin substitute is included in the graft or skin substitute procedure. CMS states that debridement codes 11000–11047 and 97597–97598 are not separately reportable when the debridement is included in skin graft or skin substitute procedures coded 15050–15278.
However, debridement and skin substitute application can appear on the same claim when the services are genuinely distinct, supported by documentation, and allowed under applicable payer rules.
Skin substitute application codes describe placement of a graft or substitute over a prepared wound. Relevant CPT codes may include 15271–15278, depending on the procedure, site, and wound size.
When tissue is removed to prepare the same wound for the graft or skin substitute, that preparation is generally considered part of the application service. CMS’s 2026 NCCI Policy Manual specifically states that debridement of a skin wound before a graft or skin substitute is included in the procedure.
Therefore, performing debridement immediately before applying the product does not automatically justify reporting both services.
Consider a chronic ulcer with devitalized tissue. During the encounter, the clinician removes nonviable tissue, prepares the wound bed, and applies a skin substitute to the same site.
In this situation, billing the debridement separately may create a bundling problem. The debridement is part of preparing the recipient site. Documentation should describe the wound, tissue removed, depth treated, and application, but those details do not by themselves make debridement separately billable.
Codes 97597 and 97598 describe selective debridement, while 11042–11047 are used for surgical debridement based on tissue level. CMS emphasizes that the selected code must reflect the actual tissue removed and documented depth.
Two procedures performed on the same date can sometimes be distinct, but occurring during one visit is not enough to support separate reporting.
One possible example is treatment of separate anatomic sites where the debridement is unrelated to the skin substitute application. The record should identify separate wounds, procedures, locations, and medical necessity. An appropriate modifier may be necessary.
CMS explains that NCCI-associated modifiers such as 59, XE, XP, XS, and XU may be used in appropriate circumstances, including separate encounters or anatomic sites. They should not simply bypass a bundling edit.
Coders should review the specific NCCI edit, payer policy, and documentation before adding modifier 59 or an X{EPSU} modifier.
Strong documentation is the foundation of accurate wound care billing. For debridement, the record should support what was removed and why the service was medically necessary.
Useful documentation includes:
CMS guidance indicates that documentation for selective debridement should include an objective wound assessment and description of the instruments used. For surgical debridement, the record should support the actual depth and tissue level removed.
Documentation should describe the care accurately, not simply support a desired code.
Several errors can cause denials or compliance concerns when these procedures are reported together.
Before submitting a claim, confirm:
This review is valuable for practices managing high volumes of wound care claims. Effective Woundcare billing services should combine coding knowledge, documentation review, payer requirements, and claim level quality checks.
Medicare rules are a starting point, not a substitute for reviewing the payer’s current policy. Commercial insurers and Medicaid programs may apply different requirements, coverage limitations, or authorization rules.
For Medicare claims, the 2026 NCCI Policy Manual is an important reference. CMS also maintains wound care billing and coding guidance.
Because coding policies can change, practices should verify current NCCI edits and payer policies before applying a modifier or reporting two procedures together.
Generally, not when 97597 represents debridement performed to prepare the same recipient wound for the skin substitute. CMS considers this type of debridement included in the graft or skin substitute procedure.
Not simply because both procedures were performed. If 11042 represents preparation of the same wound for the skin substitute, it is generally included. A separately reportable service requires a distinct clinical circumstance supported by the record and applicable payer rules.
Modifier 59 does not automatically make bundled services separately payable. It may be appropriate only when the services meet requirements for a distinct service, such as a separate anatomic site or other qualifying circumstance under applicable NCCI rules.
Documentation should identify wound location, measurements, tissue characteristics, procedure performed, technique, depth, tissue removed, medical necessity, and skin substitute application details. Separate wounds should be clearly distinguished.
The safest approach is to focus on what each service actually represents. Debridement performed to prepare the same wound for a skin substitute is generally included in the application procedure. Separate reporting requires a genuinely distinct service, appropriate documentation, and compliance with applicable NCCI and payer requirements.
Careful coding, documentation, and claim review can reduce denials while supporting accurate reimbursement. Practices should verify current Medicare and payer guidance before submitting claims, particularly as wound care coding and coverage policies continue to change.